Characterisation and development of 2448 and C51 : novel monoclonal antibodies targeting ovarian and breast cancer
Monoclonal antibody (mAb) therapy represents an attractive targeted approach for the treatment of cancer. Nevertheless, only a limited number of antigens on solid tumours have been exploited. To address the diverse clinical spectrum of ovarian and breast cancer, the discovery of new antigen targets...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/72381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Be the first to leave a comment!